Difference between revisions of "Part:BBa K4447003"
Line 29: Line 29:
 
== Cloning RifMo into pET28b vector ==
 
== Cloning RifMo into pET28b vector ==
 
<div style="text-align:justify;">
 
<div style="text-align:justify;">
−
As part of the development of our FRET-based biosensor for rifampicin [https://parts.igem.org/Part:BBa_K5439003 (BBa_K5439003)], we decided to clone the basic coding sequence into pET28b to contribute to the characterization and use of the basic part. After amplification by PCR and digestion with <i> NdeI </i> and <i> XhoI </i>, the insert was ligated into the vector using T4 ligase (Invitrogen) at both a 3:1 and 5:1 molar ratio, using 50 ng of vector. The restriction digestion conditions are shown in <b> Table 1 </b>, while the ligation conditions are shown in <b> Table 2 </b>.
+
As part of the development of our FRET-based biosensor for rifampicin [https://parts.igem.org/Part:BBa_K5439003 (BBa_K5439003)], we decided to clone the basic coding sequence into pET28b to contribute to the characterization and use of the basic part. After amplification by PCR and digestion with <i> NdeI </i> and <i> XhoI </i> <b> Figure 3 </b>, the insert was ligated into the vector using T4 ligase (Invitrogen) at both a 3:1 and 5:1 molar ratio, using 50 ng of vector. The restriction digestion conditions are shown in <b> Table 1 </b>, while the ligation conditions are shown in <b> Table 2 </b>.
  
 
{| class="wikitable" style="margin:auto; text-align:center; length: 80%"
 
{| class="wikitable" style="margin:auto; text-align:center; length: 80%"
Line 51: Line 51:
 
| style="text-align:center;" style="width: 80%;" | Total Volume || 20 µL
 
| style="text-align:center;" style="width: 80%;" | Total Volume || 20 µL
 
|}
 
|}
 +
 +
<html>
 +
<head>
 +
<style>
 +
    figure {
 +
        text-align: center;
 +
    }
 +
 +
    figcaption {
 +
        font-size: 12px;
 +
    }
 +
 +
</style>
 +
</head>
 +
<body>
 +
    <figure>
 +
        <img src="https://static.igem.wiki/teams/5439/registry-parts/digestion-rifmo.webp" width="300">
 +
        <figcaption><b>Figure 3</b>.Bacterial transformation of ECFP_mVenus with IpfF in E.coli BL21 in LB agar with kanamycin (50 μg/mL).
 +
.</figcaption>
 +
    </figure>
 +
</body>
 +
</html>
 +
 +
<html>
 +
<head>
 +
<style>
 +
    figure {
 +
        text-align: center;
 +
    }
 +
 +
    figcaption {
 +
        font-size: 12px;
 +
    }
 +
 +
</style>
 +
</head>
 +
<body>
 +
    <figure>
 +
        <img src="https://static.igem.wiki/teams/5439/registry-parts/transformadarifmo.webp" width="300">
 +
        <figcaption><b>Figure 3</b>.Bacterial transformation of ECFP_mVenus with IpfF in E.coli BL21 in LB agar with kanamycin (50 μg/mL).
 +
.</figcaption>
 +
    </figure>
 +
</body>
 +
</html>
 +
 +
 +
 +
<html>
 +
<head>
 +
<style>
 +
    figure {
 +
        text-align: center;
 +
    }
 +
 +
    figcaption {
 +
        font-size: 12px;
 +
    }
 +
 +
</style>
 +
</head>
 +
<body>
 +
    <figure>
 +
        <img src="https://static.igem.wiki/teams/5439/registry-parts/cpcrrifmo.webp" width="300">
 +
        <figcaption><b>Figure 3</b>.Bacterial transformation of ECFP_mVenus with IpfF in E.coli BL21 in LB agar with kanamycin (50 μg/mL).
 +
.</figcaption>
 +
    </figure>
 +
</body>
 +
</html>
 +
  
 
{| class="wikitable" style="margin:auto; text-align:center; length: 60%"
 
{| class="wikitable" style="margin:auto; text-align:center; length: 60%"
Line 67: Line 136:
 
| style="text-align:center;" style="width: 60%;" | Nuclease-free water || 4.4 μL |||  0 μL
 
| style="text-align:center;" style="width: 60%;" | Nuclease-free water || 4.4 μL |||  0 μL
 
|}
 
|}
 +
 +
  
 
=References=
 
=References=

Revision as of 07:29, 2 October 2024


RifMo coding sequence

Rifampicin monooxygenase coding sequence from Nocardia farcinica. This enzyme catalyzes the oxidation of rifampicin, thereby inactivating its antibiotic activity. It constitutes a secondary rifampicin resistance factor.

Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    INCOMPATIBLE WITH RFC[12]
    Illegal NotI site found at 1225
  • 21
    INCOMPATIBLE WITH RFC[21]
    Illegal XhoI site found at 1456
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    COMPATIBLE WITH RFC[1000]


Usage and Biology

Rifampicin is a potent antibiotic against tuberculosis and other mycobacterial infections, but an extensive usage of it and its derivatives has contributed to bacterial resistance, which neutralizes antibiotic activity. The presence of rifampicin in water bodies represents a persintent thread, because of the hazardous potential it has to aquatic organisms and human health (Cai et al., 2019).

In our project, rifampicin monooxygenase (EC 1.14.13.211) is used as a detector for the presence of rifampicin by catalyzing the hydroxylation of rifampicin to 2'-N-hydroxy-4-oxo-rifampicin, a metabolite with much lower antimicrobial activity. As shown in Figure 1, this reaction requires NADPH as a reagent and, therefore, gives NADP+ as a reaction product. Consequently, it is possible to evaluate the presence of rifampicin through a coupled reaction employing a NADP+/NADPH colorimetric assay.

Figure 1. Chemical reaction for rifampicin monooxygenase (RifMo).

Rifampicin monooxygenase, as pictured below in Figure 2 is a dimeric protein that has 474 amino acids in length and 51.4 kDa in weight (Hoshino et al., 2010). Koteva and collaborators (2018) reported a Michaelis constant of 12 µM for rifampicin, concluding it has a unique affinity for this substrate.

Figure 2. Three-dimensional structure of RifMo.


Characterization: TecMonterreyGDL 2024

Cloning RifMo into pET28b vector

As part of the development of our FRET-based biosensor for rifampicin (BBa_K5439003), we decided to clone the basic coding sequence into pET28b to contribute to the characterization and use of the basic part. After amplification by PCR and digestion with NdeI and XhoI Figure 3 , the insert was ligated into the vector using T4 ligase (Invitrogen) at both a 3:1 and 5:1 molar ratio, using 50 ng of vector. The restriction digestion conditions are shown in Table 1 , while the ligation conditions are shown in Table 2 .

Table 1. Restriction digest conditions.
Component Volume
Restriction Enzyme 10X Buffer 5 µL
DNA (1 μg/μL) 1 µL
NdeI restriction enzyme 1 µL
XhoI restriction enzyme 1 µL
BSA (10 μg/μL) 0.2 µL
Nuclease-free water To 20 µL
Total Volume 20 µL

Figure 3.Bacterial transformation of ECFP_mVenus with IpfF in E.coli BL21 in LB agar with kanamycin (50 μg/mL). .

Figure 3.Bacterial transformation of ECFP_mVenus with IpfF in E.coli BL21 in LB agar with kanamycin (50 μg/mL). .


Figure 3.Bacterial transformation of ECFP_mVenus with IpfF in E.coli BL21 in LB agar with kanamycin (50 μg/mL). .


Table 2. Ligation conditions.
Component 3:1 ratio 5:1 ratio
pET28b 50 ng (6.7 μL) 50 ng (6.7 μL)
RifMo 39.74 ng (6.7 μL) 66.23 ng (11 μL)
T4 ligase buffer 2 μL 2 μL
T4 ligase 0.2 μL 0.2 μL
Nuclease-free water 4.4 μL 0 μL


References

[1]. Cai, W., Weng, X., & Chen, Z. (2019). Highly efficient removal of antibiotic rifampicin from aqueous solution using green synthesis of recyclable nano-Fe3O4. Environmental pollution (Barking, Essex : 1987), 247, 839–846. https://doi.org/10.1016/j.envpol.2019.01.108

[2]. Hoshino, Y., Fujii, S., Shinonaga, H., Arai, K., Saito, F., Fukai, T., Satoh, H., Miyazaki, Y., & Ishikawa, J. (2010). Monooxygenation of rifampicin catalyzed by the rox gene product of Nocardia farcinica: structure elucidation, gene identification and role in drug resistance. The Journal of antibiotics, 63(1), 23–28. https://doi.org/10.1038/ja.2009.116

[3]. Koteva, K., Cox, G., Kelso, J. K., Surette, M. D., Zubyk, H. L., Ejim, L., Stogios, P., Savchenko, A., Sørensen, D., & Wright, G. D. (2018). Rox, a Rifamycin Resistance Enzyme with an Unprecedented Mechanism of Action. Cell Chemical Biology, 25(4), 403-412.e5. https://doi.org/10.1016/j.chembiol.2018.01.009

‌